PL2295049T3 - Leczenie chorób autoimmunologicznych - Google Patents

Leczenie chorób autoimmunologicznych

Info

Publication number: PL2295049T3
Authority: PL; Poland
Prior art keywords: autoimmune diseases; treatment; neuritis; uveitis; invention describes
Prior art date: 2005-09-09

Application number

PL10174280T

Other languages

English (en)

Inventor

Rainer Albert

Nigel Graham Cooke

Barbara Nuesslein-Hildesheim

Sven Weiler

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-09

Filing date

2006-09-07

Publication date

2015-04-30

2006-09-07 Application filed by Novartis Ag filed Critical Novartis Ag

2015-04-30 Publication of PL2295049T3 publication Critical patent/PL2295049T3/pl

Links

208000023275 Autoimmune disease Diseases 0.000 title abstract 2
206010029240 Neuritis Diseases 0.000 abstract 2
206010046851 Uveitis Diseases 0.000 abstract 1
150000001414 amino alcohols Chemical class 0.000 abstract 1
206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
201000006417 multiple sclerosis Diseases 0.000 abstract 1
201000001119 neuropathy Diseases 0.000 abstract 1
230000003287 optical effect Effects 0.000 abstract 1
125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL10174280T 2005-09-09 2006-09-07 Leczenie chorób autoimmunologicznych PL2295049T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US71599005P	2005-09-09	2005-09-09
EP10174280.7A EP2295049B1 (en)	2005-09-09	2006-09-07	Treatment of autoimmune diseases
EP06793341A EP1926483B1 (en)	2005-09-09	2006-09-07	Treatment of autoimmune diseases

Publications (1)

Publication Number	Publication Date
PL2295049T3 true PL2295049T3 (pl)	2015-04-30

Family

ID=37056992

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL06793341T PL1926483T3 (pl)	2005-09-09	2006-09-07	Leczenie chorób autoimmunologicznych
PL10174280T PL2295049T3 (pl)	2005-09-09	2006-09-07	Leczenie chorób autoimmunologicznych

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL06793341T PL1926483T3 (pl)	2005-09-09	2006-09-07	Leczenie chorób autoimmunologicznych

Country Status (28)

Country	Link
US (1)	US20080200438A1 (pl)
EP (2)	EP1926483B1 (pl)
JP (4)	JP5244598B2 (pl)
KR (3)	KR101476591B1 (pl)
CN (1)	CN101257899B (pl)
AT (1)	ATE489948T1 (pl)
AU (2)	AU2006289100B2 (pl)
BR (1)	BRPI0615906A2 (pl)
CA (2)	CA2820510A1 (pl)
CY (1)	CY1111285T1 (pl)
DE (1)	DE602006018629D1 (pl)
DK (2)	DK2295049T3 (pl)
ES (2)	ES2529724T3 (pl)
IL (2)	IL189665A (pl)
JO (1)	JO2655B1 (pl)
MA (1)	MA29787B1 (pl)
MX (1)	MX2008003170A (pl)
NO (1)	NO20081727L (pl)
NZ (2)	NZ588372A (pl)
PL (2)	PL1926483T3 (pl)
PT (2)	PT2295049E (pl)
RU (2)	RU2424795C2 (pl)
SG (1)	SG165364A1 (pl)
SI (2)	SI1926483T1 (pl)
TN (1)	TNSN08103A1 (pl)
TW (2)	TWI372620B (pl)
WO (1)	WO2007028821A2 (pl)
ZA (1)	ZA200801694B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7781617B2 (en)	2004-07-16	2010-08-24	Kyorin Pharmaceutical Co., Ltd	Effective use method of medicaments and method of preventing expression of side effect
EP1806338B1 (en)	2004-10-12	2016-01-20	Kyorin Pharmaceutical Co., Ltd.	Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof
PL1932522T3 (pl) *	2005-10-07	2012-09-28	Kyorin Seiyaku Kk	Środek terapeutyczny do leczenia choroby wątroby zawierający jako składnik czynny pochodną 2-amino-1,3-propanodiolu
TWI389683B (zh) *	2006-02-06	2013-03-21	Kyorin Seiyaku Kk	A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
CA2659598A1 (en) *	2006-08-08	2008-02-14	Kyorin Pharmaceutical Co., Ltd.	Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
JP5140593B2 (ja) *	2006-08-08	2013-02-06	杏林製薬株式会社	アミノアルコール誘導体及びそれらを有効成分とする免疫抑制剤
WO2008099781A1 (ja) *	2007-02-13	2008-08-21	Kyorin Pharmaceutical Co., Ltd.	アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤
TW200946105A (en)	2008-02-07	2009-11-16	Kyorin Seiyaku Kk	Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient
CA2724592A1 (en) *	2008-05-20	2009-11-26	Kyorin Pharmaceutical Co., Ltd.	Agent for maintenance of induced remission
WO2010020609A1 (en) *	2008-08-18	2010-02-25	Novartis Ag	Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies
BR112012028248A2 (pt) *	2010-05-06	2016-08-02	Novartis Ag	derivados de sulfeto de diarila, seu uso, e kit
KR20130066630A (ko) *	2010-05-06	2013-06-20	노파르티스 아게	자가면역 질환의 치료

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5141421A (en) *	1991-12-17	1992-08-25	Carrier Corporation	Nested coupling mechanism for scroll machines
DE4428835A1 (de) *	1994-08-01	1996-02-08	Schering Ag	Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
KR20000075745A (ko) *	1997-02-27	2000-12-26	가마후라 아키오	의약 조성물
DE60235900D1 (de) *	2001-09-27	2010-05-20	Kyorin Seiyaku Kk	Osuppressivum
CA2461212C (en)	2001-09-27	2010-08-17	Kyorin Pharmaceutical Co., Ltd.	Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
JP4571497B2 (ja) *	2002-09-19	2010-10-27	杏林製薬株式会社	アミノアルコール誘導体とその付加塩及び免疫抑制剤
EP1575576A2 (en) *	2002-09-24	2005-09-21	Novartis AG	Organic compounds
KR100995486B1 (ko) *	2002-09-28	2010-11-22	맥네일-피피씨, 인코포레이티드	개구가 있는 쉘을 포함하는 속방성 투여형
BRPI0407658A (pt) *	2003-02-18	2006-02-21	Kyorin Seiyaku Kk	derivados de ácido aminofosfÈnico, seus sais e hidratos que atuam como moduladores de receptor de s1p e agente farmacêutico
PE20130200A1 (es) *	2003-04-08	2013-03-09	Novartis Ag	Composicion farmaceutica que contiene un agonista del receptor s1p y un alcohol de azucar
WO2005014525A2 (en) *	2003-08-12	2005-02-17	Mitsubishi Pharma Corporation	Bi-aryl compound having immunosuppressive activity
ATE449069T1 (de) *	2003-08-28	2009-12-15	Novartis Pharma Gmbh	Aminopropanolderivate
US7781617B2 (en) *	2004-07-16	2010-08-24	Kyorin Pharmaceutical Co., Ltd	Effective use method of medicaments and method of preventing expression of side effect
KR20070085465A (ko) *	2004-11-29	2007-08-27	노파르티스 아게	Ｓ１ｐ 수용체 효능제의 투여 용법
GB0504544D0 (en) *	2005-03-04	2005-04-13	Novartis Ag	Organic compounds

2006
- 2006-09-07 ES ES10174280.7T patent/ES2529724T3/es active Active
- 2006-09-07 KR KR1020147001496A patent/KR101476591B1/ko not_active Expired - Fee Related
- 2006-09-07 JO JO2006298A patent/JO2655B1/en active
- 2006-09-07 CA CA2820510A patent/CA2820510A1/en not_active Abandoned
- 2006-09-07 US US12/065,096 patent/US20080200438A1/en not_active Abandoned
- 2006-09-07 CN CN2006800328984A patent/CN101257899B/zh not_active Expired - Fee Related
- 2006-09-07 AT AT06793341T patent/ATE489948T1/de active
- 2006-09-07 PT PT10174280T patent/PT2295049E/pt unknown
- 2006-09-07 WO PCT/EP2006/066150 patent/WO2007028821A2/en not_active Ceased
- 2006-09-07 AU AU2006289100A patent/AU2006289100B2/en not_active Ceased
- 2006-09-07 DE DE602006018629T patent/DE602006018629D1/de active Active
- 2006-09-07 NZ NZ588372A patent/NZ588372A/en not_active IP Right Cessation
- 2006-09-07 KR KR1020147026128A patent/KR20140117704A/ko not_active Ceased
- 2006-09-07 MX MX2008003170A patent/MX2008003170A/es active IP Right Grant
- 2006-09-07 JP JP2008529636A patent/JP5244598B2/ja active Active
- 2006-09-07 DK DK10174280.7T patent/DK2295049T3/en active
- 2006-09-07 EP EP06793341A patent/EP1926483B1/en active Active
- 2006-09-07 EP EP10174280.7A patent/EP2295049B1/en not_active Not-in-force
- 2006-09-07 SI SI200630937T patent/SI1926483T1/sl unknown
- 2006-09-07 PL PL06793341T patent/PL1926483T3/pl unknown
- 2006-09-07 CA CA2620554A patent/CA2620554C/en not_active Expired - Fee Related
- 2006-09-07 RU RU2008113187/15A patent/RU2424795C2/ru not_active IP Right Cessation
- 2006-09-07 RU RU2011111117/15A patent/RU2493840C2/ru not_active IP Right Cessation
- 2006-09-07 BR BRPI0615906-0A patent/BRPI0615906A2/pt not_active IP Right Cessation
- 2006-09-07 PL PL10174280T patent/PL2295049T3/pl unknown
- 2006-09-07 SI SI200631889T patent/SI2295049T1/sl unknown
- 2006-09-07 DK DK06793341.6T patent/DK1926483T3/da active
- 2006-09-07 SG SG201006580-3A patent/SG165364A1/en unknown
- 2006-09-07 PT PT06793341T patent/PT1926483E/pt unknown
- 2006-09-07 NZ NZ566137A patent/NZ566137A/en not_active IP Right Cessation
- 2006-09-07 ES ES06793341T patent/ES2357426T3/es active Active
- 2006-09-08 TW TW099117063A patent/TWI372620B/zh not_active IP Right Cessation
- 2006-09-08 TW TW095133326A patent/TWI376223B/zh active
2008
- 2008-02-21 ZA ZA200801694A patent/ZA200801694B/xx unknown
- 2008-02-21 IL IL189665A patent/IL189665A/en not_active IP Right Cessation
- 2008-03-06 TN TNP2008000103A patent/TNSN08103A1/en unknown
- 2008-03-17 MA MA30758A patent/MA29787B1/fr unknown
- 2008-04-07 NO NO20081727A patent/NO20081727L/no not_active Application Discontinuation
- 2008-04-08 KR KR1020087008413A patent/KR101476451B1/ko not_active Expired - Fee Related
2010
- 2010-09-21 AU AU2010224355A patent/AU2010224355B2/en not_active Ceased
2011
- 2011-03-01 CY CY20111100242T patent/CY1111285T1/el unknown
2012
- 2012-10-17 JP JP2012230044A patent/JP6077265B2/ja not_active Expired - Fee Related
2014
- 2014-06-23 IL IL233328A patent/IL233328A0/en unknown
- 2014-09-29 JP JP2014199069A patent/JP2015025002A/ja not_active Withdrawn
2016
- 2016-09-30 JP JP2016193400A patent/JP2017019854A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
KR101476451B1 (ko)	2014-12-24
IL189665A (en)	2014-07-31
JP2017019854A (ja)	2017-01-26
JO2655B1 (en)	2012-06-17
KR20140019033A (ko)	2014-02-13
MA29787B1 (fr)	2008-09-01
WO2007028821A2 (en)	2007-03-15
JP6077265B2 (ja)	2017-02-08
TW201034659A (en)	2010-10-01
IL189665A0 (en)	2008-06-05
CY1111285T1 (el)	2015-08-05
JP2009507810A (ja)	2009-02-26
CN101257899A (zh)	2008-09-03
NZ566137A (en)	2011-05-27
NO20081727L (no)	2008-06-06
BRPI0615906A2 (pt)	2011-05-31
JP5244598B2 (ja)	2013-07-24
TW200803829A (en)	2008-01-16
JP2013010802A (ja)	2013-01-17
SI1926483T1 (sl)	2011-04-29
KR20080046231A (ko)	2008-05-26
DK1926483T3 (da)	2011-03-14
EP2295049B1 (en)	2014-11-26
CA2620554C (en)	2013-12-17
DE602006018629D1 (de)	2011-01-13
IL233328A0 (en)	2014-08-31
SG165364A1 (en)	2010-10-28
MX2008003170A (es)	2008-03-18
CN101257899B (zh)	2012-10-03
TWI372620B (en)	2012-09-21
TNSN08103A1 (en)	2009-07-14
RU2008113187A (ru)	2009-10-20
ATE489948T1 (de)	2010-12-15
EP2295049A1 (en)	2011-03-16
AU2010224355B2 (en)	2012-03-29
ZA200801694B (en)	2009-09-30
DK2295049T3 (en)	2015-02-23
NZ588372A (en)	2012-03-30
AU2006289100B2 (en)	2010-07-22
KR101476591B1 (ko)	2014-12-24
US20080200438A1 (en)	2008-08-21
SI2295049T1 (sl)	2015-03-31
ES2357426T3 (es)	2011-04-26
AU2006289100A1 (en)	2007-03-15
RU2424795C2 (ru)	2011-07-27
KR20140117704A (ko)	2014-10-07
EP1926483B1 (en)	2010-12-01
ES2529724T3 (es)	2015-02-25
PL1926483T3 (pl)	2011-05-31
PT2295049E (pt)	2015-03-02
TWI376223B (en)	2012-11-11
EP1926483A2 (en)	2008-06-04
CA2820510A1 (en)	2007-03-15
RU2011111117A (ru)	2012-09-27
JP2015025002A (ja)	2015-02-05
HK1149906A1 (en)	2011-10-21
AU2010224355A1 (en)	2010-10-14
PT1926483E (pt)	2011-03-03
CA2620554A1 (en)	2007-03-15
WO2007028821A3 (en)	2007-05-03
RU2493840C2 (ru)	2013-09-27

Publication	Publication Date	Title
IL233328A0 (en)	2014-08-31	Treatment of autoimmune diseases
TW200509892A (en)	2005-03-16	Novel aminobenzophenone compounds
WO2005032471A3 (en)	2005-07-07	Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007022470A3 (en)	2007-06-14	Methods and compositions for treating neurological disease
WO2006058868A3 (de)	2006-08-03	Substituierte pteridine zur behandlung von entzündlichen erkrankungen
TW200806325A (en)	2008-02-01	Therapeutic uses of inhibitors of RTP801
WO2005051914A8 (en)	2005-08-11	Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
PL1910338T3 (pl)	2011-02-28	Związki heterotetracykliczne jako mimetyki TPO
WO2006058867A3 (de)	2006-10-26	Substituierte pteridine zur behandlung von entzündlichen erkrankungen
UA90698C2 (en)	2010-05-25	Triazole substituted aminobenzophenone compounds
BRPI0513317A (pt)	2008-05-06	ciclosporinas para tratar doença de alzheimer
WO2009136997A3 (en)	2009-12-30	Inhibitors of human cathepsin l, cathepsin b, and cathepsin s
TW200635597A (en)	2006-10-16	Substituted pteridines for the treatment of inflammatory diseases
WO2006078576A3 (en)	2006-10-05	Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
BR0306855A (pt)	2005-04-05	Método para o tratamento de distúrbios cognitivos
MX2008002166A (es)	2008-04-22	Compuestos y composiciones como mimeticos de trombopoietina (tpo).
WO2007058862A3 (en)	2007-10-11	Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
TW200639155A (en)	2006-11-16	Thiazolidinones, their production and use as pharmaceutical agents
IL181713A0 (en)	2008-03-20	Use of il-17f for the treatment and/or prevention of neurological diseases
WO2007019080A3 (en)	2008-01-17	Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
TW200603791A (en)	2006-02-01	Compounds and compositions as cathepsin S inhibitors
TW200628453A (en)	2006-08-16	Triazole substituted aminobenzophenone compounds
BRPI0402756A (pt)	2006-02-21	método para o tratamento de distúrbios cognitivos
MX2007003281A (es)	2007-05-18	N-etilhidroxietilamina util en el tratamiento de afecciones del sistema nervioso central.